Esophageal and Gastric Varices Clinical Trial
Official title:
Trial of Monthly Versus Bi-weekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding
Many physicians suggest repeating EVL every 1-2 weeks until esophageal varices are obliterated to prevent variceal rebleedingļ¼ however, the evidences supporting the efficacy of EVL intervals of 1-2 weeks are insufficient.This randomized controlled study was conducted in order to compare the long-term results of EVL when performed at two different results from monthly and bi-weekly treatments.
Endoscopic variceal ligation (EVL) is a safe and simple procedure now being used on a widening scale. A lot of patients who undergo endoscopic treatment for esophageal varices eventually require additional treatment for recurrent varices. Many physicians suggest repeating EVL every 1-2 weeks until esophageal varices are obliterated to prevent variceal rebleedingļ¼ however, the evidences supporting the efficacy of EVL intervals of 1-2 weeks are insufficient.This randomized controlled study was conducted in order to compare the long-term results of EVL when performed at two different results from monthly and bi-weekly treatments. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05055713 -
A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism
|
N/A | |
| Recruiting |
NCT02945930 -
Study the Safety and Efficacy of "Compont Medical Glue" in the Treatment of Esophagogastric Varices
|
N/A | |
| Completed |
NCT04823780 -
The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis
|
||
| Completed |
NCT03244332 -
HEMOCC Study. Hemostasis in Cirrhotic Children.
|
N/A | |
| Completed |
NCT02991612 -
Rifaximin in Patients With Gastroesophageal Variceal Bleeding
|
N/A | |
| Recruiting |
NCT02964195 -
Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding
|
N/A | |
| Completed |
NCT00004641 -
A Study to Prevent Complications of High Blood Pressure Caused by Hepatitis in Patients With Cirrhosis
|
Phase 2 | |
| Completed |
NCT02593799 -
Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study
|
||
| Recruiting |
NCT02385422 -
The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleeding
|
Phase 4 | |
| Completed |
NCT00838864 -
Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding
|
Phase 4 | |
| Not yet recruiting |
NCT03130127 -
Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis
|
N/A | |
| Active, not recruiting |
NCT05979935 -
Prediction of Esophageal Varices in Liver Cirrhosis Using Tongue Bioinformatics
|
||
| Recruiting |
NCT02504723 -
Carvedilol as an Adjunct to Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal Bleeding
|
Phase 4 | |
| Withdrawn |
NCT00475592 -
Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy
|
N/A | |
| Completed |
NCT05331768 -
Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin Therapy
|
N/A | |
| Completed |
NCT04210297 -
Development and Validation of an Noninvasive Model for Predicting High Risk Esophageal Varices in Cirrhosis
|
||
| Recruiting |
NCT02311608 -
Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails
|
N/A | |
| Completed |
NCT04976543 -
Safety of Anticoagulant Therapy After Endoscopic Treatment
|
Phase 4 | |
| Not yet recruiting |
NCT05978752 -
Clinical Study on Endoscopic Management of GOV1 Esophagogastric Varices
|
N/A | |
| Recruiting |
NCT02695732 -
The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding
|
Phase 4 |